PubMed

Risk factor identification and assessment in hypertension and diabetes (RIAHD) study.

Skrtic S, Niklason A, Leoo T, Hedner T; RIAHD Study Group.

Blood Press. 2006;15(6):367-74.PMID: 17472028 [PubMed - indexed for MEDLINE]Related articles

IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies.

Huth C, Heid IM, Vollmert C, Gieger C, Grallert H, Wolford JK, Langer B, Thorand B, Klopp N, Hamid YH, Pedersen O, Hansen T, Lyssenko V, Groop L, Meisinger C, Döring A, Löwel H, Lieb W, Hengstenberg C, Rathmann W, Martin S, Stephens JW, Ireland H, Mather H, Miller GJ, Stringham HM, Boehnke M, Tuomilehto J, Boeing H, Möhlig M, Spranger J, Pfeiffer A, Wernstedt I, Niklason A, López-Bermejo A, Fernández-Real JM, Hanson RL, Gallart L, Vendrell J, Tsiavou A, Hatziagelaki E, Humphries SE, Wichmann HE, Herder C, Illig T.

Diabetes. 2006 Oct;55(10):2915-21.PMID: 17003362 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum leptin and myocardial infarction in hypertension.

Wallerstedt SM, Eriksson AL, Niklason A, Ohlsson C, Hedner T.

Blood Press. 2004;13(4):243-6.PMID: 15581339 [PubMed - indexed for MEDLINE]Related articles

Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).

Niklason A, Hedner T, Niskanen L, Lanke J; Captopril Prevention Project Study Group.

J Hypertens. 2004 Mar;22(3):645-52.PMID: 15076172 [PubMed - indexed for MEDLINE]Related articles

Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population.

Eriksson AL, Skrtic S, Niklason A, Hultén LM, Wiklund O, Hedner T, Ohlsson C.

Eur Heart J. 2004 Mar;25(5):386-91.PMID: 15033250 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.

Niskanen L, Hedner T, Hansson L, Lanke J, Niklason A; CAPPP Study Group.

Diabetes Care. 2001 Dec;24(12):2091-6.PMID: 11723089 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE.

Lancet. 1999 Feb 20;353(9153):611-6.PMID: 10030325 [PubMed - indexed for MEDLINE]Related articles

The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status.

Hansson L, Hedner T, Lindholm L, Niklason A, Luomanmäki K, Niskanen L, Lanke J, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE.

Blood Press. 1997 Nov;6(6):365-7.PMID: 9495662 [PubMed - indexed for MEDLINE]Related articles